Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shoulder Joint | 14 | 2023 | 740 | 1.970 |
Why?
|
| Rotator Cuff | 12 | 2024 | 348 | 1.410 |
Why?
|
| Range of Motion, Articular | 13 | 2023 | 1593 | 1.000 |
Why?
|
| Shoulder | 4 | 2023 | 299 | 0.930 |
Why?
|
| Menisci, Tibial | 7 | 2021 | 266 | 0.820 |
Why?
|
| Patellofemoral Joint | 5 | 2022 | 133 | 0.800 |
Why?
|
| Tendons | 4 | 2021 | 555 | 0.800 |
Why?
|
| Bursitis | 3 | 2017 | 85 | 0.670 |
Why?
|
| Shoulder Pain | 2 | 2017 | 152 | 0.650 |
Why?
|
| Achilles Tendon | 3 | 2024 | 181 | 0.620 |
Why?
|
| Suture Techniques | 5 | 2014 | 774 | 0.570 |
Why?
|
| Shoulder Impingement Syndrome | 1 | 2017 | 35 | 0.560 |
Why?
|
| Suture Anchors | 2 | 2014 | 81 | 0.540 |
Why?
|
| Cadaver | 11 | 2023 | 1362 | 0.520 |
Why?
|
| Tendinopathy | 3 | 2024 | 174 | 0.510 |
Why?
|
| Clavicle | 1 | 2017 | 224 | 0.460 |
Why?
|
| Joint Instability | 5 | 2022 | 802 | 0.450 |
Why?
|
| Tenodesis | 1 | 2013 | 50 | 0.420 |
Why?
|
| Humerus | 1 | 2014 | 272 | 0.390 |
Why?
|
| Bone Screws | 2 | 2013 | 533 | 0.390 |
Why?
|
| Ligaments, Articular | 5 | 2022 | 306 | 0.380 |
Why?
|
| Patellar Dislocation | 2 | 2022 | 67 | 0.370 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2017 | 1882 | 0.370 |
Why?
|
| Humeral Fractures | 1 | 2014 | 283 | 0.360 |
Why?
|
| Femoral Neck Fractures | 1 | 2012 | 143 | 0.350 |
Why?
|
| Bone Cements | 1 | 2012 | 319 | 0.340 |
Why?
|
| Patella | 5 | 2022 | 310 | 0.340 |
Why?
|
| Finite Element Analysis | 3 | 2024 | 441 | 0.290 |
Why?
|
| Movement | 1 | 2014 | 1461 | 0.280 |
Why?
|
| Wound Healing | 2 | 2017 | 2795 | 0.260 |
Why?
|
| Orthopedic Procedures | 5 | 2012 | 1279 | 0.260 |
Why?
|
| Fractures, Open | 1 | 2007 | 106 | 0.260 |
Why?
|
| Ankle Joint | 2 | 2023 | 450 | 0.250 |
Why?
|
| Scapula | 2 | 2020 | 175 | 0.240 |
Why?
|
| Athletic Injuries | 4 | 2013 | 1244 | 0.240 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3561 | 0.240 |
Why?
|
| Fractures, Bone | 1 | 2017 | 2041 | 0.230 |
Why?
|
| Femoral Fractures | 2 | 2019 | 375 | 0.230 |
Why?
|
| Peroneal Nerve | 1 | 2004 | 80 | 0.230 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2007 | 423 | 0.220 |
Why?
|
| Humeral Head | 1 | 2023 | 41 | 0.210 |
Why?
|
| Knee Injuries | 3 | 2014 | 495 | 0.200 |
Why?
|
| Relaxin | 1 | 2022 | 42 | 0.200 |
Why?
|
| Thoracic Vertebrae | 1 | 2007 | 614 | 0.200 |
Why?
|
| Patellar Ligament | 1 | 2022 | 65 | 0.200 |
Why?
|
| Fracture Fixation | 1 | 2004 | 369 | 0.190 |
Why?
|
| Mechanical Phenomena | 2 | 2023 | 142 | 0.190 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2012 | 1414 | 0.190 |
Why?
|
| Stress, Mechanical | 4 | 2024 | 1670 | 0.190 |
Why?
|
| Tibial Fractures | 1 | 2004 | 276 | 0.180 |
Why?
|
| Arthroscopy | 5 | 2021 | 969 | 0.180 |
Why?
|
| Spinal Fractures | 1 | 2007 | 702 | 0.170 |
Why?
|
| Activities of Daily Living | 2 | 2024 | 2419 | 0.170 |
Why?
|
| Dyskinesias | 1 | 2020 | 79 | 0.160 |
Why?
|
| Injections, Intra-Articular | 2 | 2017 | 279 | 0.160 |
Why?
|
| Robotics | 3 | 2016 | 807 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 4959 | 0.150 |
Why?
|
| Knee Joint | 4 | 2022 | 1656 | 0.150 |
Why?
|
| Bone Nails | 1 | 2019 | 221 | 0.140 |
Why?
|
| Fractures, Malunited | 1 | 2018 | 82 | 0.140 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2019 | 160 | 0.140 |
Why?
|
| Musculoskeletal Diseases | 1 | 2022 | 598 | 0.130 |
Why?
|
| Acromioclavicular Joint | 1 | 2016 | 78 | 0.120 |
Why?
|
| Recovery of Function | 3 | 2017 | 2971 | 0.120 |
Why?
|
| Humans | 47 | 2024 | 766117 | 0.120 |
Why?
|
| Radiography | 3 | 2014 | 6943 | 0.120 |
Why?
|
| Taxoids | 1 | 2017 | 665 | 0.110 |
Why?
|
| Tenotomy | 1 | 2013 | 53 | 0.110 |
Why?
|
| Osteotomy | 1 | 2018 | 835 | 0.100 |
Why?
|
| Cementation | 1 | 2012 | 92 | 0.100 |
Why?
|
| Swine | 4 | 2014 | 5986 | 0.100 |
Why?
|
| Middle Aged | 16 | 2024 | 223083 | 0.100 |
Why?
|
| Connecticut | 1 | 2012 | 365 | 0.090 |
Why?
|
| Male | 25 | 2024 | 363935 | 0.090 |
Why?
|
| Femur | 1 | 2018 | 1309 | 0.090 |
Why?
|
| Histological Techniques | 1 | 2011 | 193 | 0.090 |
Why?
|
| Fracture Fixation, Internal | 1 | 2018 | 981 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2015 | 771 | 0.090 |
Why?
|
| Rupture | 2 | 2010 | 444 | 0.090 |
Why?
|
| Hip Fractures | 1 | 2019 | 995 | 0.090 |
Why?
|
| Ankle | 2 | 2024 | 353 | 0.090 |
Why?
|
| Joints | 1 | 2011 | 321 | 0.080 |
Why?
|
| Automobile Driving | 1 | 2015 | 441 | 0.080 |
Why?
|
| Aged | 14 | 2024 | 171219 | 0.080 |
Why?
|
| Osteoarthritis | 1 | 2016 | 1051 | 0.080 |
Why?
|
| Arthroplasty, Replacement | 1 | 2011 | 312 | 0.070 |
Why?
|
| Braces | 1 | 2009 | 139 | 0.070 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2007 | 76 | 0.070 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 20137 | 0.070 |
Why?
|
| Upper Extremity | 1 | 2012 | 684 | 0.070 |
Why?
|
| Sports | 1 | 2013 | 699 | 0.070 |
Why?
|
| Medically Uninsured | 1 | 2012 | 838 | 0.070 |
Why?
|
| Paraplegia | 1 | 2007 | 159 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 3530 | 0.060 |
Why?
|
| Health Care Costs | 2 | 2017 | 3243 | 0.060 |
Why?
|
| Tibia | 2 | 2022 | 1064 | 0.060 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2011 | 789 | 0.060 |
Why?
|
| Cocaine | 2 | 2001 | 944 | 0.060 |
Why?
|
| Female | 14 | 2024 | 396233 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2019 | 6612 | 0.060 |
Why?
|
| Models, Anatomic | 2 | 2021 | 678 | 0.060 |
Why?
|
| Rats | 4 | 2024 | 23717 | 0.050 |
Why?
|
| Pneumothorax | 1 | 2007 | 393 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2017 | 6254 | 0.050 |
Why?
|
| Health Care Reform | 1 | 2012 | 1257 | 0.050 |
Why?
|
| Adult | 8 | 2018 | 223139 | 0.050 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2012 | 1188 | 0.050 |
Why?
|
| Hematoma | 1 | 2007 | 765 | 0.050 |
Why?
|
| Animals | 12 | 2024 | 168800 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2022 | 65219 | 0.050 |
Why?
|
| Los Angeles | 1 | 2022 | 244 | 0.050 |
Why?
|
| Medicare | 2 | 2017 | 6820 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2024 | 533 | 0.040 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2000 | 91 | 0.040 |
Why?
|
| Culture | 1 | 2024 | 622 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 12803 | 0.040 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2019 | 31 | 0.040 |
Why?
|
| Reference Values | 1 | 2007 | 4909 | 0.040 |
Why?
|
| Myocardial Ischemia | 2 | 2000 | 2132 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2012 | 2520 | 0.040 |
Why?
|
| beta-Defensins | 1 | 2019 | 58 | 0.040 |
Why?
|
| Tenascin | 1 | 2019 | 61 | 0.040 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2019 | 147 | 0.040 |
Why?
|
| Spinal Cord Injuries | 1 | 2007 | 929 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2019 | 109 | 0.040 |
Why?
|
| Massachusetts | 1 | 2012 | 8882 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2022 | 966 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18321 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2019 | 81565 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 259 | 0.040 |
Why?
|
| Joint Deformities, Acquired | 1 | 2018 | 35 | 0.040 |
Why?
|
| Survival Rate | 1 | 2012 | 12827 | 0.040 |
Why?
|
| Anesthetics, General | 1 | 1999 | 151 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 59515 | 0.040 |
Why?
|
| Spinal Fusion | 1 | 2007 | 1307 | 0.040 |
Why?
|
| Triamcinolone | 1 | 2017 | 68 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 20700 | 0.030 |
Why?
|
| Radium | 1 | 2017 | 70 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2019 | 831 | 0.030 |
Why?
|
| Universities | 1 | 2022 | 1004 | 0.030 |
Why?
|
| Equipment Failure | 1 | 2019 | 580 | 0.030 |
Why?
|
| Androstenes | 1 | 2017 | 177 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2000 | 1516 | 0.030 |
Why?
|
| Phenylthiohydantoin | 1 | 2017 | 206 | 0.030 |
Why?
|
| Fibrosis | 1 | 2022 | 2073 | 0.030 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1999 | 772 | 0.030 |
Why?
|
| Cadherins | 1 | 2019 | 900 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 2017 | 750 | 0.030 |
Why?
|
| Pressure | 1 | 2016 | 1171 | 0.030 |
Why?
|
| Photogrammetry | 1 | 2013 | 77 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2019 | 1416 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2024 | 8113 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 1999 | 838 | 0.020 |
Why?
|
| Nitriles | 1 | 2017 | 981 | 0.020 |
Why?
|
| Workers' Compensation | 1 | 2012 | 150 | 0.020 |
Why?
|
| Benzamides | 1 | 2017 | 1376 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2242 | 0.020 |
Why?
|
| Rotation | 1 | 2013 | 513 | 0.020 |
Why?
|
| Observer Variation | 1 | 2016 | 2611 | 0.020 |
Why?
|
| Calcium | 2 | 2000 | 5770 | 0.020 |
Why?
|
| Safety | 1 | 2015 | 1157 | 0.020 |
Why?
|
| Government Programs | 1 | 2012 | 278 | 0.020 |
Why?
|
| Acute Disease | 1 | 2020 | 7237 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2012 | 15808 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 2795 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 36548 | 0.020 |
Why?
|
| Drug Costs | 1 | 2017 | 1195 | 0.020 |
Why?
|
| Private Sector | 1 | 2012 | 396 | 0.020 |
Why?
|
| Tendon Transfer | 1 | 2010 | 125 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2011 | 530 | 0.020 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2011 | 388 | 0.020 |
Why?
|
| Models, Biological | 1 | 2024 | 9445 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2012 | 54812 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 59868 | 0.020 |
Why?
|
| Myocardium | 1 | 2000 | 4766 | 0.020 |
Why?
|
| Kidney | 1 | 2001 | 7072 | 0.020 |
Why?
|
| Equipment Design | 1 | 2013 | 3489 | 0.020 |
Why?
|
| Liver | 1 | 2001 | 7559 | 0.010 |
Why?
|
| ROC Curve | 1 | 2013 | 3614 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 5791 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2019 | 8062 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6208 | 0.010 |
Why?
|
| Algorithms | 1 | 2022 | 14066 | 0.010 |
Why?
|
| United States | 3 | 2017 | 72920 | 0.010 |
Why?
|
| Cyanides | 1 | 2000 | 82 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2000 | 164 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2001 | 410 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2000 | 201 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 16040 | 0.010 |
Why?
|
| Chloralose | 1 | 1999 | 14 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 2000 | 149 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2019 | 12130 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2012 | 9657 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 610 | 0.010 |
Why?
|
| Urethane | 1 | 1999 | 37 | 0.010 |
Why?
|
| Xylazine | 1 | 1999 | 12 | 0.010 |
Why?
|
| Papillary Muscles | 1 | 2000 | 192 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2000 | 11509 | 0.010 |
Why?
|
| Boston | 1 | 2012 | 9335 | 0.010 |
Why?
|
| Pentobarbital | 1 | 1999 | 153 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 88819 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 5889 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 5531 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 2000 | 502 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 2001 | 608 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 10737 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2000 | 656 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2001 | 855 | 0.010 |
Why?
|
| Logistic Models | 1 | 2012 | 13273 | 0.010 |
Why?
|
| Necrosis | 1 | 2001 | 1614 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 24276 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2012 | 3407 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39243 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2000 | 1886 | 0.010 |
Why?
|
| Perfusion | 1 | 2000 | 1408 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41684 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 2000 | 499 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2000 | 1601 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 5510 | 0.010 |
Why?
|
| Catheterization | 1 | 1999 | 1426 | 0.010 |
Why?
|
| Ketamine | 1 | 1999 | 527 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 6215 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 10380 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 15827 | 0.010 |
Why?
|
| Incidence | 1 | 2009 | 21513 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 4342 | 0.010 |
Why?
|
| Mice | 3 | 2001 | 81839 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 2000 | 3094 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1999 | 4188 | 0.000 |
Why?
|
| Oxygen | 1 | 2000 | 4247 | 0.000 |
Why?
|
| Time Factors | 1 | 2010 | 40108 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 9540 | 0.000 |
Why?
|
| Heart Ventricles | 1 | 2000 | 3833 | 0.000 |
Why?
|
| Heart | 1 | 1999 | 4419 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2001 | 12775 | 0.000 |
Why?
|
| Apoptosis | 1 | 2001 | 9508 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1999 | 8532 | 0.000 |
Why?
|
| Heart Failure | 1 | 2000 | 11837 | 0.000 |
Why?
|
Concepts
(238)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_